Geranylgeranylacetone formulations and retinal delivery thereof
AssigneeRohto USA, Inc.
InventorHiroaki Serizawa
Life of this patent
Estimating the term…
Abstract
Provided herein is a pharmaceutical formulation comprising at least one geranylgeranyl acetone in the form of an eye drop. Also provided herein are methods of treating neural diseases or disorders by administering such pharmaceutical formulations.
Claims18
1-42. (canceled)
A method of delivering geranylgeranyl acetone (GGA) into a retina of a subject, the method comprising administering topically on an ocular surface of the subject a composition comprising geranylgeranyl acetone (GGA).
A method of treating a retinal disease in a subject, the method comprising administering topically on an ocular surface of the subject a composition comprising geranylgeranyl acetone (GGA).
A method of inhibiting a retinal optical nerve damage in a subject, the method comprising administering topically on an ocular surface of the subject a composition comprising geranylgeranyl acetone (GGA).
(canceled)
Dependencies are inferred from the claim text.